Trial Profile
Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment with Elamipretide in Patients Hospitalized with Congestion due to Heart Failure
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Elamipretide (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- 18 Jun 2016 New trial record